![Jennifer King](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jennifer King
Consultant / Advisor at Ally Bridge Group HK Ltd
Profile
Jennifer King is currently working as an Advisor at Ally Bridge Group HK Ltd since 2022.
She previously worked as a Senior Director-Business Development at Shire Plc and as a Senior Vice President-Business Development at Intellia Therapeutics, Inc. She also served as an Independent Non-Executive Director at Exopharm Ltd.
from 2021 to 2023.
Dr. King holds an undergraduate degree from Massachusetts Institute of Technology, an MBA from Northeastern University, and a doctorate from Stanford University School of Medicine.
Jennifer King active positions
Companies | Position | Start |
---|---|---|
Ally Bridge Group HK Ltd
![]() Ally Bridge Group HK Ltd Investment ManagersFinance Ally Bridge Group HK Ltd (Ally Bridge) is a private equity firm founded in 2011 by Frank Yu. The firm is headquartered in Hong Kong with additional office in the US. | Consultant / Advisor | 31/12/2021 |
Former positions of Jennifer King
Companies | Position | End |
---|---|---|
EXOPHARM | Director/Board Member | 21/02/2023 |
SHIRE | Corporate Officer/Principal | - |
INTELLIA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Training of Jennifer King
Massachusetts Institute of Technology | Undergraduate Degree |
Stanford University School of Medicine | Doctorate Degree |
Northeastern University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
INTELLIA THERAPEUTICS, INC. | Health Technology |
Private companies | 3 |
---|---|
Shire Plc
![]() Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Exopharm Ltd.
![]() Exopharm Ltd. Pharmaceuticals: MajorHealth Technology Exopharm Ltd. engages in the research and development of biopharmaceutical drugs. The company was founded by Ian Dixon and Gregor Lichtfuss in 2013 and is headquartered in Camberwell, Australia. | Health Technology |
Ally Bridge Group HK Ltd
![]() Ally Bridge Group HK Ltd Investment ManagersFinance Ally Bridge Group HK Ltd (Ally Bridge) is a private equity firm founded in 2011 by Frank Yu. The firm is headquartered in Hong Kong with additional office in the US. | Finance |
- Stock Market
- Insiders
- Jennifer King